Loading company…
Pharmadax Genesis develops nuclear medicine drugs and provides molecular imaging diagnosis.
Founded in 2016 in Jiaxing, China, Pharmadax Genesis is a drug research and development contract organization focused on radioactive medicines. It develops diagnostic and therapeutic nuclear medicine products and provides molecular imaging diagnosis. In December 2024, China National Nuclear Corporation Capital led its Series A2 round. The company planned to fund pipeline research and an industrial base for radioactive drugs.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in